This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Donald S. Robinson, MD; Alexander Nies, MD; C. Lewis Ravaris, PhD, MD; John O. Ives, MD; Diantha Bartlett, MS

Arch Gen Psychiatry. 1978;35(5):629-635.

Abstract
• There is renewed interest in the clinical pharmacology of phenelzine sulfate and other monoamine oxidase (MAO) inhibitors. Newer clinical and analytic techniques recently have been applied to investigations of this class of drugs in man. The results show that drugs such as phenelzine are effective in nonendogenous depression and phobic disorders. Clinical response to phenelzine is related to platelet MAO inhibition and dosage per unit body weight. High percent MAO inhibition in platelets at two weeks is associated with greater improvement after a six-week course of treatment. Our data show that a safe, effective phenelzine dose is 1 mg/kg body weight per day. These results have delineated the pharmacologic and therapeutic effects of phenelzine and support a continuing role for MAO inhibitors in psychopharmacology.

Author Affiliations
From the Departments of Medicine and Pharmacology (Dr Robinson), Psychiatry (Drs Nies, Ravaris, Ives), and Epidemiology (Ms Bartlett), University of Vermont College of Medicine, Burlington.

Footnotes
Reprint requests to Clinical Pharmacology Unit, University of Vermont College of Medicine, Burlington, VT 05401 (Dr Robinson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tyramine Pharmacokinetics and Reduced Bioavailability with Food
VanDenBerg et al.
J Clin Pharmacol 2003;43:604-609.
ABSTRACT | FULL TEXT  

A Reappraisal of Atypical Depression
QUITKIN et al.
Am. J. Psychiatry 2003;160:798-800.
FULL TEXT  

Atypical Depression: A Reappraisal
Parker et al.
Am. J. Psychiatry 2002;159:1470-1479.
ABSTRACT | FULL TEXT  

Treatment of Atypical Depression With Cognitive Therapy or Phenelzine: A Double-blind, Placebo-Controlled Trial
Jarrett et al.
Arch Gen Psychiatry 1999;56:431-437.
ABSTRACT | FULL TEXT  

A Placebo-Controlled Comparison of Nortriptyline and Phenelzine in Maintenance Therapy of Elderly Depressed Patients
Georgotas et al.
Arch Gen Psychiatry 1989;46:783-786.
ABSTRACT  

Assessment and Treatment of Affective Illness in the Elderly
Jenike
J Geriatr Psychiatry Neurol 1988;1:89-107.
 

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Becker et al.
Science 1983;221:476-478.
ABSTRACT  

Atypical Depression
Davidson et al.
Arch Gen Psychiatry 1982;39:527-534.
ABSTRACT  

Treatment of Traumatic War Neurosis With Phenelzine
Hogben and Cornfield
Arch Gen Psychiatry 1981;38:440-445.
ABSTRACT  

Monoamine Oxidase Inhibitors: A Review of Antidepressant Effectiveness
Quitkin et al.
Arch Gen Psychiatry 1979;36:749-760.
ABSTRACT  

Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic Subjects
Groshong et al.
Arch Gen Psychiatry 1978;35:1198-1205.
ABSTRACT